title: Epidemiological evaluation of the outcomes after video-assisted thoracoscopic talcage in neoplastic pleurisy.
abstract: OBJECTIVE
  Clinical-epidemiological investigations for further assessing the importance of video-assisted thoracoscopy in the treatment y of patients with neoplastic pleurisy.
  
  
  METHODS
  The researches included a group of 72 patients (31.9% men and 68.1% women aged 31-81 years, mean age ± 60 years) with neoplastic pleurisy who underwent pleural symphysis by video-assisted thoracoscopic talcage. For statistical-mathematical processing and interpretation the Pearson correlation index with the level of significance at p = 0.05 and highly significant at p < 0.005 was used.
  
  
  RESULTS
  Neoplastic pleurisy prevalently affected the age groups 51-80 years (84.9%). Dyspnea was present in all cases, and patient history at the time of admission revealed 14 conditions, of which 25% were lung cancers. Macroscopically nodular and vegetative tumors were found in 66.7% of cases. An amount of 1000-2000 ml of pleural fluid was found in 44.5% of the cases and a serocitrin appearance in 50%. In 23.6% of the cases cytology results were positive for malignancy and in 13.8% suspicious. In 65.2% of the cases the pleural fluid was exudative and anatomopathology was suggestive of adenocarcinoma in 34.7% of the cases and breast cancer in 18%. The prevalence of recurrences varied from 1 month to more than 7 months, with 36.4% for 1-2 months.
  
  
  CONCLUSIONS
  The obtained additional data support the important role of pleural symphysis by video-assisted thoracoscopic talcage in the patients with neoplastic pleurisy.
authors.forename: M
authors.initials: M
authors.lastname: Bosînceanu
authors.forename: C
authors.initials: C
authors.lastname: Sandu
authors.forename: C E
authors.initials: CE
authors.lastname: Roată
authors.forename: Luminiţa Roxana
authors.initials: LR
authors.lastname: Ionescu
authors.forename: L
authors.initials: L
authors.lastname: Miron
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005079:Excipients / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000150:complications*; D010998:Pleurisy / Q000453:epidemiology / Q000209:etiology / Q000601:surgery*; D018700:Pleurodesis; D015995:Prevalence; D012307:Risk Factors; D012383:Romania / Q000453:epidemiology; D013627:Talc / Q000008:administration & dosage*; D020775:Thoracic Surgery, Video-Assisted; D013906:Thoracoscopy; D016896:Treatment Outcome
chemical_list: D005079:Excipients; D013627:Talc